Showing results (81-90 of 150) with videos related to
Sort By:
Pageof 15
Stem Cell Reports|December 3, 2015
Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived HepatocytesKate Cameron, Rosanne Tan, Wolfgang Schmidt-Heck, et al.Cloning and Stem Cells|May 16, 2008
The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatmentJudy Fletcher, Wei Cui, Kay Samuel, et al.Science Translational Medicine|May 20, 2021
Cellular senescence inhibits renal regeneration after injury in mice, with senolytic treatment promoting repairKatie J Mylonas, Eoin D O'Sullivan, Duncan Humphries, et al.Cytotherapy|July 5, 2017
Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosisAlasdair R Fraser, Chloe Pass, Paul Burgoyne, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signalingThomas G Bird, Wei-Yu Lu, Luke Boulter, et al.Diabetes|April 24, 2013
Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cellsMaria João Lima, Kenneth R Muir, Hilary M Docherty, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 11, 2021
Fibroblast growth factor 7 releasing particles enhance islet engraftment and improve metabolic control following islet transplantation in mice with diabetesSalamah M Alwahsh, Omar Qutachi, Philip J Starkey Lewis, et al.Journal of Hepatology|December 3, 2014
Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinomaOscar W H Yeung, Chung-Mau Lo, Chang-Chun Ling, et al.Virology|January 24, 2006
Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X proteinVictor V Keasler, Herve Lerat, Charles R Madden, et al.The Journal of Clinical Investigation|February 18, 2015
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibitedLuke Boulter, Rachel V Guest, Timothy J Kendall, et al.Pageof 15